MOORESTOWN, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc., (“TRHC”) (NASDAQ:TRHC) announced today that Chief Pharmacotherapy Officer Robert L. Alesiani, PharmD, BCGP, has been named the 2018 Hugo H. Schaefer Award winner by the American Pharmacists Association (APhA).

The APhA Board of Trustees selected Dr. Alesiani for this award based on his outstanding contributions to the APhA, the profession of pharmacy, and society. The awards and honors program at APhA is the most comprehensive and prestigious within the profession.

“It is truly an honor to be chosen by APhA for the Hugo H. Schaefer Award,” said Dr. Alesiani. “I look forward to continuing to improve patients’ lives, to help to hone the skills of our next generation of clinicians, and to make a positive impact in the profession. The future of pharmacy is bright!”

As Chief Pharmacotherapy Officer, Dr. Alesiani leads the Clinical Team at CareKinesis, a Tabula Rasa HealthCare company. He is one of the first clinical pharmacists in the U.S. with expertise to provide precision medicine, in particular, pharmacogenomic testing coordination and translation for people on high-risk medications. A Board-Certified Geriatric Pharmacist (BCGP), he has extensive knowledge in the field of geriatric pharmaceutical care, and he has guided his entire team of eligible pharmacists to 100% BCGP certification.

“Dr. Alesiani and I have worked together for decades,” stated Calvin H. Knowlton, PhD, Chairman, CEO and Founder of Tabula Rasa HealthCare. “Bob always has been in the vanguard of pharmacy and pharmaceutical care. He has a tremendous knowledge and experience in hospice and palliative care. He endlessly dedicates himself to bettering society through his practice. I believe he is more than deserving of this award.”

The award will be presented to Dr. Alesiani at the APhA Annual Meeting and Exposition in Nashville, Tennessee, March 16-19, 2018.

Dr. Alesiani received a BS in Marine Sciences from The Richard Stockton University (1979) in New Jersey, a BPharm from the University of the Sciences in Philadelphia (1987) and his PharmD from the University of Florida (2005), where he graduated cum laude and received the Outstanding Graduating Clinician Award.  He returned in 2016 to complete a certification in Pharmacogenomic Translation and Application. 

About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.  Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, visit: www.TRHC.com.

Contact
Dianne Semingson                                                                             
dsemingson@TRHC.com      
T: 215-870-0829